This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Korkola, J. E. Articles by Waldman, F. M. Search for Related Content PubMed PubMed Citation Articles by Korkola, J. E. Articles by Waldman, F. M.

Differentiation of Lobular versus Ductal Breast Carcinomas by Expression Microarray Analysis¹

Comprehensive Cancer Center [J. E. K., S. D., J. F., A. L. H. E., K. L. C., R. M. J., F. M. W.], and Departments of Surgery [E. S. H.], Pathology [Y-Y. C.], and Laboratory Medicine [R. M. J., F. M. W.], University of California San Francisco, San Francisco, California 94143-0808, and Geraldine Brush Cancer Research Institute, California Pacific Medical Center, San Francisco, California 94115 [S. H. D.]

Invasive lobular and ductal breast tumors have distinct histologies and clinical presentation. Other than altered expression of E-cadherin, little is known about the underlying biology that distinguishes the tumor subtypes. We used cDNA microarrays to identify genes differentially expressed between lobular and ductal tumors. Unsupervised clustering of tumors failed to distinguish between the two subtypes. Prediction analysis for microarrays (PAM) was able to predict tumor type with an accuracy of 93.7%. Genes that were significantly differentially expressed between the two groups were identified by MaxT permutation analysis using t tests (20 cDNA clones and 10 unique genes), significance analysis for microarrays (33 cDNA clones and 15 genes, at an estimated false discovery rate of 2%), and PAM (31 cDNAs and 15 genes). There were 8 genes identified by all three of these related methods (E-cadherin, survivin, cathepsin B, TPI1, SPRY1, SCYA14, TFAP2B, and thrombospondin 4), and an additional 3 that were identified by significance analysis for microarrays and PAM (osteopontin, HLA-G, and CHC1). To validate the differential expression of these genes, 7 of them were tested by real-time quantitative PCR, which verified that they were differentially expressed in lobular versus ductal tumors. In conclusion, specific changes in gene expression distinguish lobular from ductal breast carcinomas. These genes may be important in understanding the basis of phenotypic differences among breast cancers.

This article has been cited by other articles:

				M. Fischer, A. Oberthuer, B. Brors, Y. Kahlert, M. Skowron, H. Voth, P. Warnat, K. Ernestus, B. Hero, and F. Berthold Differential Expression of Neuronal Genes Defines Subtypes of Disseminated Neuroblastoma with Favorable and Unfavorable Outcome Clin. Cancer Res., September 1, 2006; 12(17): 5118 - 5128. [Abstract] [Full Text] [PDF]

				A. Gupta, B. R.G. Williams, S. M. Hanash, and J. Rawwas Cellular Retinoic Acid-Binding Protein II Is a Direct Transcriptional Target of MycN in Neuroblastoma Cancer Res., August 15, 2006; 66(16): 8100 - 8108. [Abstract] [Full Text] [PDF]

				Z. Mi, H. Guo, P. Y. Wai, C. Gao, and P. C. Kuo Integrin-linked kinase regulates osteopontin-dependent MMP-2 and uPA expression to convey metastatic function in murine mammary epithelial cancer cells Carcinogenesis, June 1, 2006; 27(6): 1134 - 1145. [Abstract] [Full Text] [PDF]

				N. Nguyen, A. Kuliopulos, R. A. Graham, and L. Covic Tumor-Derived Cyr61(CCN1) Promotes Stromal Matrix Metalloproteinase-1 Production and Protease-Activated Receptor 1-Dependent Migration of Breast Cancer Cells. Cancer Res., March 1, 2006; 66(5): 2658 - 2665. [Abstract] [Full Text] [PDF]

				J S Reis-Filho, C Westbury, and J-Y Pierga The impact of expression profiling on prognostic and predictive testing in breast cancer. J. Clin. Pathol., March 1, 2006; 59(3): 225 - 231. [Abstract] [Full Text] [PDF]

				I.-J. Kim, H. C. Kang, S.-G. Jang, K. Kim, S.-A Ahn, H.-J. Yoon, S. N. Yoon, and J.-G. Park Oligonucleotide microarray analysis of distinct gene expression patterns in colorectal cancer tissues harboring BRAF and K-ras mutations Carcinogenesis, March 1, 2006; 27(3): 392 - 404. [Abstract] [Full Text] [PDF]

				D. E. Stange, B. Radlwimmer, F. Schubert, F. Traub, A. Pich, G. Toedt, F. Mendrzyk, U. Lehmann, R. Eils, H. Kreipe, et al. High-Resolution Genomic Profiling Reveals Association of Chromosomal Aberrations on 1q and 16p with Histologic and Genetic Subgroups of Invasive Breast Cancer Clin. Cancer Res., January 15, 2006; 12(2): 345 - 352. [Abstract] [Full Text] [PDF]

				H. Asanuma, T. Torigoe, K. Kamiguchi, Y. Hirohashi, T. Ohmura, K. Hirata, M. Sato, and N. Sato Survivin Expression Is Regulated by Coexpression of Human Epidermal Growth Factor Receptor 2 and Epidermal Growth Factor Receptor via Phosphatidylinositol 3-Kinase/AKT Signaling Pathway in Breast Cancer Cells Cancer Res., December 1, 2005; 65(23): 11018 - 11025. [Abstract] [Full Text] [PDF]

				K Jirstrom, L Ryden, L Anagnostaki, B Nordenskjold, O Stal, S Thorstenson, G Chebil, P-E Jonsson, M Ferno, and G Landberg Pathology parameters and adjuvant tamoxifen response in a randomised premenopausal breast cancer trial J. Clin. Pathol., November 1, 2005; 58(11): 1135 - 1142. [Abstract] [Full Text] [PDF]

				E. Blaveri, J. P. Simko, J. E. Korkola, J. L. Brewer, F. Baehner, K. Mehta, S. DeVries, T. Koppie, S. Pejavar, P. Carroll, et al. Bladder Cancer Outcome and Subtype Classification by Gene Expression Clin. Cancer Res., June 1, 2005; 11(11): 4044 - 4055. [Abstract] [Full Text] [PDF]

				M. Cristofanilli, A. Gonzalez-Angulo, N. Sneige, S.-W. Kau, K. Broglio, R. L. Theriault, V. Valero, A. U. Buzdar, H. Kuerer, T. A. Buccholz, et al. Invasive Lobular Carcinoma Classic Type: Response to Primary Chemotherapy and Survival Outcomes J. Clin. Oncol., January 1, 2005; 23(1): 41 - 48. [Abstract] [Full Text] [PDF]

				L. W. Fisher, A. Jain, M. Tayback, and N. S. Fedarko Small Integrin Binding Ligand N-Linked Glycoprotein Gene Family Expression in Different Cancers Clin. Cancer Res., December 15, 2004; 10(24): 8501 - 8511. [Abstract] [Full Text] [PDF]

				Z. Mi, H. Guo, P. Y. Wai, C. Gao, J. Wei, and P. C. Kuo Differential Osteopontin Expression in Phenotypically Distinct Subclones of Murine Breast Cancer Cells Mediates Metastatic Behavior J. Biol. Chem., November 5, 2004; 279(45): 46659 - 46667. [Abstract] [Full Text] [PDF]

				P. N. Span, F. C.G.J. Sweep, E. T.G. Wiegerinck, V. C.G. Tjan-Heijnen, P. Manders, L. V.A.M. Beex, and J. B. de Kok Survivin Is an Independent Prognostic Marker for Risk Stratification of Breast Cancer Patients Clin. Chem., November 1, 2004; 50(11): 1986 - 1993. [Abstract] [Full Text] [PDF]

				M Lacroix, R-A Toillon, and G Leclercq Stable 'portrait' of breast tumors during progression: data from biology, pathology and genetics Endocr. Relat. Cancer, September 1, 2004; 11(3): 497 - 522. [Abstract] [Full Text] [PDF]